|
1
|
Huber LC, Distler O, Tarner I, Gay RE, Gay
S and Pap T: Synovial fibroblasts: Key players in rheumatoid
arthritis. Rheumatol (Oxford). 45:669–675. 2006.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Mathiessen A and Conaghan PG: Synovitis in
osteoarthritis: Current understanding with therapeutic
implications. Arthritis Res Ther. 19(18)2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Storch H, Zimmermann B, Resch B,
Tykocinski LO, Moradi B, Horn P, Kaya Z, Blank N, Rehart S, Thomsen
M, et al: Activated human B cells induce inflammatory fibroblasts
with cartilage-destructive properties and become functionally
suppressed in return. Ann Rheum Dis. 75:924–32. 2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Wojdasiewicz P, Poniatowski ŁA and
Szukiewicz D: The role of inflammatory and anti-inflammatory
cytokines in the pathogenesis of osteoarthritis. Mediators Inflamm.
2014(561459)2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Pelletier JP, Martel-Pelletier J and
Abramson SB: Osteoarthritis, an inflammatory disease: Potential
implication for the selection of new therapeutic targets. Arthritis
Rheum. 44:1237–1247. 2001.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Malemud CJ: Biologic basis of
osteoarthritis: State of the evidence. Curr Opin Rheumatol.
27:289–294. 2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Barnes S, Prasain J, D'Alessandro T,
Arabshahi A, Botting N, Lila MA, Jackson G, Janle E and Weaver CM:
The metabolism and analysis of isoflavones and other dietary
polyphenols in foods and biological systems. Food Funct. 2:235–244.
2011.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Barnes S: The biochemistry, chemistry and
physiology of the isoflavones in soybeans and their food products.
Lymphat Res Biol. 8:89–98. 2010.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Beck V, Rohr U and Jungbauer A:
Phytoestrogens derived from red clover: An alternative to estrogen
replacement therapy? J Steroid Biochem Mol Biol. 94:499–518.
2005.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Munro IC, Harwood M, Hlywka JJ, Stephen
AM, Doull J, Flamm WG and Adlercreutz H: Soy isoflavones: A safety
review. Nutr Rev. 61:1–33. 2003.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Vitale DC, Piazza C, Melilli B, Drago F
and Salomone S: Isoflavones: Estrogenic activity, biological effect
and bioavailability. Eur J Drug Metab Pharmacokinet. 38:15–25.
2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Morito K, Hirose T, Kinjo J, Hirakawa T,
Okawa M, Nohara T, Ogawa S, Inoue S, Muramatsu M and Masamune Y:
Interaction of phytoestrogens with estrogen receptors alpha and
beta. Biol Pharm Bull. 24:351–356. 2001.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Rodriguez-Roque MJ, Rojas-Grau MA,
Elez-Martinez P and Martin-Belloso O: Soymilk phenolic compounds,
isoflavones and antioxidant activity as affected by in vitro
gastrointestinal digestion. Food Chem. 136:206–212. 2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Chacko BK, Chandler RT, D'Alessandro TL,
Mundhekar A, Khoo NK, Botting N, Barnes S and Patel PP:
Anti-inflammatory effects of isoflavones are dependent on flow and
human endothelial cell PPARgamma. J Nutr. 137:351–356.
2007.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Hong H, Landauer MR, Foriska MA and Ledney
GD: Antibacterial activity of the soy isoflavone genistein. J Basic
Microbiol. 46:329–335. 2006.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Kang JL, Lee HW, Lee HS, Pack IS, Chong Y,
Castranova V and Koh Y: Genistein prevents nuclear factor-kappa B
activation and acute lung injury induced by lipopolysaccharide. Am
J Respir Crit Care Med. 164:2206–2212. 2001.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Verdrengh M, Jonsson IM, Holmdahl R and
Tarkowski A: Genistein as an anti-inflammatory agent. Inflamm Res.
52:341–346. 2003.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Hooshmand S, Soung do Y, Lucas EA,
Madihally SV, Levenson CW and Arjmandi BH: Genistein reduces the
production of proinflammatory molecules in human chondrocytes. J
Nutr Biochem. 18:609–614. 2007.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Li J, Li J, Yue Y, Hu Y, Cheng W, Liu R,
Pan X and Zhang P: Genistein suppresses tumor necrosis factor
alpha-induced inflammation via modulating reactive oxygen
species/Akt/nuclear factor κB and adenosine monophosphate-activated
protein kinase signal pathways in human synoviocyte MH7A cells.
Drug Des Devel Ther. 8:315–323. 2014.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Choi EY, Jin JY, Lee JY, Choi JI, Choi IS
and Kim SJ: Anti-inflammatory effects and the underlying mechanisms
of action of daidzein in murine macrophages stimulated with
Prevotella intermedia lipopolysaccharide. J Periodontal Res.
47:204–211. 2012.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Sheu F, Lai HH and Yen GC: Suppression
effect of soy isoflavones on nitric oxide production in RAW 264.7
macrophages. J Agric Food Chem. 49:1767–1772. 2001.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Yamagishi Y, Someya A, Imai K, Nagao J and
Nagaoka I: Evaluation of the anti-inflammatory actions of various
functional food materials including glucosamine on synovial cells.
Mol Med Rep. 16:1353–1359. 2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Yamagishi Y, Someya A and Nagaoka I:
Citrulline cooperatively exerts an anti-inflammatory effect on
synovial cells with glucosamine and N-acetylglucosamine. Biomed
Rep. 13:37–42. 2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Someya A, Ikegami T, Sakamoto K and
Nagaoka I: Glucosamine downregulates the IL-1beta-induced
expression of proinflammatory cytokine genes in human synovial MH7A
cells by O-GlcNAc modification-dependent and -independent
mechanisms. PLoS One. 11(e0165158)2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Barnes PJ and Karin M: Nuclear
factor-kappaB: A pivotal transcription factor in chronic
inflammatory diseases. N Engl J Med. 336:1066–1071. 1997.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Kyriakis JM and Avruch J: Mammalian MAPK
signal transduction pathways activated by stress and inflammation:
A 10-year update. Physiol Rev. 92:689–737. 2012.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Tak PP and Firestein GS: NF-kappaB: A key
role in inflammatory diseases. J Clin Invest. 107:7–11.
2001.PubMed/NCBI View
Article : Google Scholar
|
|
28
|
Hamalainen M, Nieminen R, Vuorela P,
Heinonen M and Moilanen E: Anti-inflammatory effects of flavonoids:
genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and
NF-kappaB activations, whereas flavone, isorhamnetin, naringenin,
and pelargonidin inhibit only NF-kappaB activation along with their
inhibitory effect on iNOS expression and NO production in activated
macrophages. Mediators Inflamm. 2007(45673)2007.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Weber A, Wasiliew P and Kracht M:
Interleukin-1 (IL-1) pathway. Sci Signal. 3(cm1)2010.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Kawai T and Akira S: TLR signaling. Semin
Immunol. 19:24–32. 2007.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Zandi E and Karin M: Bridging the gap:
Composition, regulation, and physiological function of the IkappaB
kinase complex. Mol Cell Biol. 19:4547–4551. 1999.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Zandi E, Chen Y and Karin M: Direct
phosphorylation of IkappaB by IKKalpha and IKKbeta: Discrimination
between free and NF-kappaB-bound substrate. Science. 281:1360–1363.
1998.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Sabio G and Davis RJ: TNF and MAP kinase
signalling pathways. Semin Immunol. 26:237–245. 2014.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Georganas C, Liu H, Perlman H, Hoffmann A,
Thimmapaya B and Pope RM: Regulation of IL-6 and IL-8 expression in
rheumatoid arthritis synovial fibroblasts: The dominant role for
NF-kappa B but not C/EBP beta or c-Jun. J Immunol. 165:7199–7206.
2000.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Saccani S, Pantano S and Natoli G:
p38-Dependent marking of inflammatory genes for increased NF-kappa
B recruitment. Nat Immunol. 3:69–75. 2002.PubMed/NCBI View
Article : Google Scholar
|
|
36
|
Hoffmann E, Dittrich-Breiholz O, Holtmann
H and Kracht M: Multiple control of interleukin-8 gene expression.
J Leukoc Biol. 72:847–855. 2002.PubMed/NCBI
|
|
37
|
Hoffmann E, Thiefes A, Buhrow D,
Dittrich-Breiholz O, Schneider H, Resch K and Kracht M:
MEK1-dependent delayed expression of Fos-related antigen-1
counteracts c-Fos and p65 NF-kappaB-mediated interleukin-8
transcription in response to cytokines or growth factors. J Biol
Chem. 280:9706–9718. 2005.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Srirangan S and Choy EH: The role of
interleukin 6 in the pathophysiology of rheumatoid arthritis. Ther
Adv Musculoskelet Dis. 2:247–56. 2010.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Takahashi A, de Andres MC, Hashimoto K,
Itoi E and Oreffo RO: Epigenetic regulation of interleukin-8, an
inflammatory chemokine, in osteoarthritis. Osteoarthritis
Cartilage. 23:1946–1954. 2015.PubMed/NCBI View Article : Google Scholar
|
